{"transactions":[{"id":2473565,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":132414,"kind":"person","name":"Harrell James Archie Jr","position":1,"cik":"0001738462","reported_name":"Harrell James Archie Jr","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-12-14T17:16:21.000Z","date":"2021-12-10","kind":"purchase","acquired":true,"shares":1093,"price":1.57,"value":1716.01,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired under the Issuer's 2016 Employee Stock Purchase Plan."}],"balance_after":36766,"source":{"system":"sec-edgar","filing":"0001879785-21-000038","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1738462/000187978521000038/edgar.xml","form_type":"4"}},{"id":2670291,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":132414,"kind":"person","name":"Harrell James Archie Jr","position":1,"cik":"0001738462","reported_name":"Harrell James Archie Jr","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-06-14T17:02:33.000Z","date":"2021-06-10","kind":"purchase","acquired":true,"shares":7493,"price":2.28,"value":17084.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired under the Issuer's 2016 Employee Stock Purchase Plan."}],"balance_after":35673,"source":{"system":"sec-edgar","filing":"0001192482-21-000499","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1738462/000119248221000499/edgar.xml","form_type":"4"}},{"id":2892224,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":132414,"kind":"person","name":"Harrell James Archie Jr","position":1,"cik":"0001738462","reported_name":"Harrell James Archie Jr","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-28T16:07:10.000Z","date":"2021-01-26","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest over four years, with the first 25% vesting on the first anniversary of the grant date, and the remainder vesting in equal monthly installments over the following 36 months, subject to the reporting person's continued service on each such vesting date."}],"balance_after":150000,"derivative":{"exercise_price":3.32,"expiration_date":"2031-01-26","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001192482-21-000117","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1738462/000119248221000117/edgar.xml","form_type":"4"}},{"id":2946746,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":132414,"kind":"person","name":"Harrell James Archie Jr","position":1,"cik":"0001738462","reported_name":"Harrell James Archie Jr","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-12-14T16:17:06.000Z","date":"2020-12-10","kind":"purchase","acquired":true,"shares":171,"price":2.278,"value":389.538,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired under the Issuer's 2016 Employee Stock Purchase Plan."}],"balance_after":28180,"source":{"system":"sec-edgar","filing":"0001192482-20-000820","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1738462/000119248220000820/edgar.xml","form_type":"4"}},{"id":3113549,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":132414,"kind":"person","name":"Harrell James Archie Jr","position":1,"cik":"0001738462","reported_name":"Harrell James Archie Jr","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-06-11T21:42:28.000Z","date":"2020-06-10","kind":"purchase","acquired":true,"shares":6391,"price":2.278,"value":14558.698,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired under the Issuer's 2016 Employee Stock Purchase Plan."}],"balance_after":28009,"source":{"system":"sec-edgar","filing":"0001192482-20-000494","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1738462/000119248220000494/edgar.xml","form_type":"4"}},{"id":3113548,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":132414,"kind":"person","name":"Harrell James Archie Jr","position":1,"cik":"0001738462","reported_name":"Harrell James Archie Jr","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-06-11T21:42:28.000Z","date":"2020-06-09","kind":"purchase","acquired":true,"shares":10000,"price":2.5,"value":25000.0,"ownership":{"direct":true},"balance_after":21618,"source":{"system":"sec-edgar","filing":"0001192482-20-000494","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1738462/000119248220000494/edgar.xml","form_type":"4"}},{"id":3178034,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":132414,"kind":"person","name":"Harrell James Archie Jr","position":1,"cik":"0001738462","reported_name":"Harrell James Archie Jr","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-04-13T18:02:53.000Z","date":"2020-04-09","kind":"grant","acquired":true,"shares":268000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth of the shares subject to the stock option will vest on the first anniversary of the date of grant, and the remaining three-fourths of the shares subject to the stock option will vest in equal monthly installments over the following 36 months."}],"balance_after":268000,"derivative":{"exercise_price":2.57,"expiration_date":"2030-04-09","underlying":"Common Stock","underlying_shares":268000},"source":{"system":"sec-edgar","filing":"0001578563-20-000014","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1738462/000157856320000014/primary_doc.xml","form_type":"4"}},{"id":3345402,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":132414,"kind":"person","name":"Harrell James Archie Jr","position":1,"cik":"0001738462","reported_name":"Harrell James Archie Jr","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2019-12-11T16:28:41.000Z","date":"2019-12-10","kind":"purchase","acquired":true,"shares":3064,"price":2.8475,"value":8724.74,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired under the Issuer's 2016 Employee Stock Purchase Plan."}],"balance_after":11618,"source":{"system":"sec-edgar","filing":"0001578563-19-000038","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1738462/000157856319000038/primary_doc.xml","form_type":"4"}},{"id":3494412,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":132414,"kind":"person","name":"Harrell James Archie Jr","position":1,"cik":"0001738462","reported_name":"Harrell James Archie Jr","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Mktg & External Comm"}}],"security":"Common Stock","published_at":"2019-06-11T19:51:29.000Z","date":"2019-06-10","kind":"purchase","acquired":true,"shares":4398,"price":2.8475,"value":12523.305,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired under the Issuer's 2016 Employee Stock Purchase Plan."}],"balance_after":8554,"source":{"system":"sec-edgar","filing":"0001578563-19-000021","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1738462/000157856319000021/primary_doc.xml","form_type":"4"}},{"id":3569050,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":132414,"kind":"person","name":"Harrell James Archie Jr","position":1,"cik":"0001738462","reported_name":"Harrell James Archie Jr","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Mktg & External Comm"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-04-02T18:59:41.000Z","date":"2019-04-01","kind":"grant","acquired":true,"shares":145000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One fourth of the shares subject to the stock option will vest on the first anniversary of the date of grant, and the remaining three-fourths of the shares subject to the stock option will vest in equal monthly installments over the following 36 months."}],"balance_after":145000,"derivative":{"exercise_price":6.22,"expiration_date":"2029-04-01","underlying":"Common Stock","underlying_shares":145000},"source":{"system":"sec-edgar","filing":"0001578563-19-000009","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1738462/000157856319000009/primary_doc.xml","form_type":"4"}},{"id":3735779,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":132414,"kind":"person","name":"Harrell James Archie Jr","position":1,"cik":"0001738462","reported_name":"Harrell James Archie Jr","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Mktg & External Comm"}}],"security":"Common Stock","published_at":"2018-12-11T17:31:54.000Z","date":"2018-12-10","kind":"purchase","acquired":true,"shares":4156,"price":2.8475,"value":11834.21,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired under the Issuer's 2016 Employee Stock Purchase Plan."}],"balance_after":4156,"source":{"system":"sec-edgar","filing":"0001738462-18-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1738462/000173846218000004/primary_doc.xml","form_type":"4"}},{"id":3942757,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":132414,"kind":"person","name":"Harrell James Archie Jr","position":1,"cik":"0001738462","reported_name":"Harrell James Archie Jr","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, Mktg & External Comm"}}],"security":"Stock Option (right to buy)","published_at":"2018-05-08T16:34:07.000Z","date":"2018-05-07","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The grant shall vest one-fourth on May 7, 2019, and the remaining three-fourth vest in 36-monthly installments beginning on June 7, 2019, provided that Mr. Harrell is then an employee of the Company."}],"balance_after":125000,"derivative":{"exercise_price":4.11,"expiration_date":"2028-05-06","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001738462-18-000003","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1738462/000173846218000003/primary_doc.xml","form_type":"4"}}]}